VRCAVerrica Pharmaceuticals Inc.

4.820USD-3.41%Mkt Cap: 82.80M $P/E:

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH…

Key Statistics

Company
Market Cap82.80M $
Enterprise Value74.10M $
Revenue (TTM)30.32M $
Gross Profit32.14M $
Net Income (TTM)-17.89M $
Revenue/Share1.831 USD
Last Price4.820 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees76
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS92511W1080
Valuation
P/E (Trailing)
P/E (Forward)-3.30
PEG
EV/EBITDA-2.85
EV/Revenue2.44
P/S2.75
P/B19.36
EPS (TTM)-1.69
EPS (Forward)-1.47
52W Range
3.28024% of range9.821
52W High9.821 USD
52W Low3.280 USD
Profitability
Gross Margin90.33%
Oper. Margin-194.46%
EBITDA Margin-85.63%
Profit Margin-50.27%
ROE-72.29%
ROA-37.95%
Growth
Revenue Growth-53.90%
Earnings Growth
Cash Flow & Leverage
Operating CF-17.63M $
CapEx (TTM)
FCF Margin-29.80%
FCF Yield-10.91%
Net Debt-9.39M $
Net Debt/EBITDA0.36
Balance Sheet
Debt/Equity0.07
Current Ratio1.45
Quick Ratio0.99
Book Value/Sh0.2510 USD
Cash/Share0.6520 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:10
Split DateJul 25, 2025
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)14.80 USD
Upside (mean)+207.1%
Target Range10.00 USD20.00 USD
$10.00+207.1% to mean$20.00
# Analysts5
Ownership
Shares Out.17.18M
Float7.90M
Insiders49.00%
Institutions27.14%
Short Interest
Short Ratio9.7d
Short % Float3.26%
Short % Out.1.68%
Shares Short287.75K
Short (prev mo.)324.68K
Technical
SMA 505.614 (-14.1%)
SMA 2006.171 (-21.9%)
Beta1.49
S&P 52W Chg18.16%
Avg Vol (30d)46.90K
Avg Vol (10d)91.15K
Technical Indicators
RSI (14)38.1
MACD-0.2166
MACD Signal-0.2024
MACD Hist.-0.0142
BB Upper5.581 USD
BB Middle5.172 USD
BB Lower4.763 USD
BB Width15.83%
ATR (14)0.4225 USD
Vol Ratio (20d)1.39x